1167PPhase I, open-label ascending dose trial of anti–CTLA-4 monoclonal antibody AGEN1884 in advanced solid malignancies, with expansion to patients refractory to recent anti–PD-1/PD-L1 therapy

B A Wilky,P Kumthekar,R Wesolowski,J J Hwang,S I Park, G Yuan,C D Dupont,M Lim, O Shebanova, J-M Cuillerot,E Dow, W Ortuzar,J J Raizer, E Drouin,N Wilson,A M Gonzalez,J M Goldberg,J S Buell, R B Stein, H Youssoufian

ANNALS OF ONCOLOGY(2018)

引用 0|浏览40
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要